Trial Details

TERMINATED
Basic Information
Clinical ID c761
Identifier NCT03281304
Trial Title A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: CP-690,500 5 mg|DRUG: CP-690,550 10 mg
Participant Information
Sponsor Pfizer
City Mobile
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2017-11-16
Primary Completion Date 2020-02-14
Completion Date 2022-03-18